Medicine

Which HIV Treatment is Best for Patients with HIV and Hepatitis C?

Juan Berenguer
Juan Berenguer

REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JUAN BERENGUER, Hospital Gregorio Marañón, Madrid
A retrospective study has thrown doubt on the theory that protease inhibitors (PIs) are a preferable antiretroviral treatment for patients co-infected with HIV and Hepatitis C virus. Previous research had suggested that PIs had a more beneficial effect on liver fibrosis than NNRTIs, but a study based at the Hospital Gregorio Marañón in Madrid has found the opposite. Derek Thorne discussed the data with Juan Berenguer.

Download this interview

Similar Interviews

  • Audio Journal of Medicine: Shorter Anti-Viral Treatment for Hepatitis C: Less Effective Than Standard Regimen">Audio Journal of Medicine: Shorter Anti-Viral Treatment for Hepatitis C: Less Effective Than Standard Regimen
  • Mitchell Shiffman REFERENCE: N Engl J Med 2007;357:124-34 MITCHELL SHIFFMAN, Virginia Commonwealth University, Richmond Standard anti-viral therapy for Hepatitis

  • Entecavir for Hepatitis B Linked to HIV Resistance
  • Moira McMahon REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007

  • Entecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation
  • CHLOE THIO, Johns Hopkins University School of Medicine REFERENCE: Abstract: 136LB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February
    1. [...] post by admin delivered by Medtrials and [...]

      Posted by   Medicine: Which HIV Treatment is Best for Patients with HIV and … by medTRIALS.info | September 23, 2007, 4:56 pm

    Post a comment